Stockscreener 앱 받기
3.465
16.71%
-0.695
시간 외 거래:
3.49
0.025
+0.72%
Recursion Pharmaceuticals Inc (RXRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
18.51%
7.67
|
6.472 | 35.54 | 5.175 | 19.22 |
| Cost Of Revenue |
8.00%
11.49
|
12.49 | 14.28 | 14.69 | 20.16 |
| Research and Development |
1.95%
89.61
|
87.90 | - | - | - |
| Costs And Expenses |
5.68%
142.64
|
134.98 | 143.87 | 177.38 | 195.45 |
| Operating Income/Loss |
5.03%
-134.97
|
-128.50 | -108.33 | -172.20 | -176.23 |
| Nonoperating Income/Loss |
38.06%
3.962
|
6.397 | 0.232 | 9.952 | 4.33 |
| Income/Loss From Continuing Operations Before Tax |
7.29%
-131.01
|
-122.11 | -108.10 | -162.25 | -171.90 |
| Income Tax Expense/Benefit, Deferred |
99.93%
-0.003
|
-4.597 | - | - | - |
| Income Tax Expense/Benefit |
99.98%
-0.001
|
-4.604 | 0.02 | 0.003 | - |
| Net Income/Loss |
11.49%
-131.00
|
-117.50 | -108.12 | -162.25 | -171.90 |
| Basic Average Shares |
0.60%
532.46
|
529.30 | 24.80 | 446.99 | 417.36 |
| Diluted Average Shares |
0.60%
532.46
|
529.30 | 24.80 | 446.99 | 417.36 |
| Basic Earnings Per Share |
13.64%
-0.25
|
-0.22 | -0.17 | -0.36 | -0.41 |
| Diluted Earnings Per Share |
13.64%
-0.25
|
-0.22 | -0.17 | -0.36 | -0.41 |
3.09%
자본화:
|
볼륨(24시간):